EUVIMEDEUVIMED entdecken
Crossref

X-ray triggered bimetallic nanoassemblies as radiosensitizers and STING agonists for a CDT/radio-immunotherapy strategy

Ruifang Chen, Jinglang Gong, Ziyi Yu, Xiyao Wu, Changjun Li, Yiling Ruan, Shouju Wang, Xiaolian Sun

Acta Biomaterialia · 2025

DOI: 10.1016/j.actbio.2024.12.030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2025. Verfasst von Ruifang Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, Key Laboratory of Drug Quality Control and Pharmacovigilance, School of Pharmacy, China Pharmaceutical Uni…. Hauptthemen laut MEDLINE: Immunotherapy, Radiation-Sensitizing Agents, Membrane Proteins, Metal Nanoparticles. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: China Pharmaceutical University, National Natural Science Foundation of China, Outstanding Youth Foundation of Jiangsu Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiotherapy (RT) is a cornerstone of cancer therapy, but its effectiveness is constrained by dose-limiting toxicity and inadequate systemic immune activation. To overcome these limitations, we have engineered an X-ray-responsive nanoassembly (sMnAu NAs) by cross-linking monodisperse MnAu nanoparticles (NPs) with radiation-responsive diselenide-containing linkers. MnAu alloy NPs not only provide Au NPs for radiosensitization, but also control Mn (0) release, which stimulates Fenton-like reaction for chemodynamic therapy and is transferred into Mn2+ to activate the STING pathway for immunotherapy. The responsive design not only improves tumor accumulation via EPR effect during circulation, but also achieves deep penetration of MnAu NPs following X-ray induced disassembly. The synergistic combination of chemodynamic therapy, radiotherapy and immunotherapy exhibits remarkable inhibition of tumor growth and metastasis. Overall, our sMnAu NAs represent a promising radiosensitizer for chemodynamic therapy and radiotherapy to enhance immunotherapy. STATEMENT OF SIGNIFICANCE: As a principal treatment modality in cancer management, RT is limited due to the co-irradiation of organs at risk and subsequent normal tissue toxicities. This study reported an X-ray responsive radiosensitizer prepared by cross-linking monodisperse MnAu NPs with diselenide-containing linkers. Upon X-ray irradiation, sMnAu NAs accumulate in tumors and disassemble into MnAu NPs, enabling deeper penetration. The increased surface area of MnAu NPs enhances the exposure of Mn(0), which reacts into Mn2+ and enhances ROS generation. The released Mn2+ activates the STING pathway, potentiating the X-ray-induced immune response. The synergistic integration of CDT, RT, and immunotherapy results in a potent suppression of tumor growth and metastasis. Collectively, this X-ray activatable CDT/radio-immunotherapy strategy holds great potential for effective cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyRadiation-Sensitizing AgentsMembrane ProteinsMetal NanoparticlesAnimalsX-RaysMiceCell Line, TumorManganeseHumansGoldFemaleSTING Protein

Stichwörter der Autor:innen

Chemodynamic therapyImmune responseRadiotherapyResponsive assemblySTING pathway

Substanzen

Radiation-Sensitizing AgentsMembrane ProteinsManganeseGoldSting1 protein, mouseSTING Protein

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines, Key Laboratory of Drug Quality Control and Pharmacovigilance, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, PR China.
  • Laboratory of Molecular Imaging, Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, PR China. Electronic address: shouju.wang@gmail.com.
  • State Key Laboratory of Natural Medicines, Key Laboratory of Drug Quality Control and Pharmacovigilance, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, PR China. Electronic address: xiaolian_sun@cp…

Förderung

  • China Pharmaceutical University
  • National Natural Science Foundation of China
  • Outstanding Youth Foundation of Jiangsu Province of China

Zitieren

APA

Chen, R., Gong, J., Yu, Z., Wu, X., Li, C., Ruan, Y., Wang, S., & Sun, X. (2025). X-ray triggered bimetallic nanoassemblies as radiosensitizers and STING agonists for a CDT/radio-immunotherapy strategy. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2024.12.030

Vancouver

Chen R, Gong J, Yu Z, Wu X, Li C, Ruan Y, et al. X-ray triggered bimetallic nanoassemblies as radiosensitizers and STING agonists for a CDT/radio-immunotherapy strategy. Acta Biomaterialia. 2025. doi:10.1016/j.actbio.2024.12.030

BibTeX
@article{Chen2025,
  author = {Chen, Ruifang and Gong, Jinglang and Yu, Ziyi and Wu, Xiyao and Li, Changjun and Ruan, Yiling and Wang, Shouju and Sun, Xiaolian},
  title = {X-ray triggered bimetallic nanoassemblies as radiosensitizers and STING agonists for a CDT/radio-immunotherapy strategy},
  journal = {Acta Biomaterialia},
  year = {2025},
  doi = {10.1016/j.actbio.2024.12.030}
}
Kostenlos starten →